A Multicentre Observational Study to Assess Long-term Outcome of Participants in the EXCELLENT Clinical Trial

Recruiting now

Conditions studied: Acute Myocardial Infarction

In brief

The PERFECT study is an observational study designed to follow patients randomised in the EXCELLENT study (NCT02669810) for 10 years. The aim is to assess the long-term clinical outcomes for patients randomised to the Standard of Care arm or the ProtheraCytes arm.

Key facts

Study ID

NCT06521047

Run by

CellProthera

People needed

48

Starts

2024-07-20

Expected to finish

2034-03-15

Last updated by the study team

2024-09-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completion of the last visit in the EXCELLENT interventional clinical trial.
• Participation must be within 10 years after the randomization in the EXCELLENT trial

You may not qualify if…

• Patients randomized to the ProtheraCytes® group who did not receive the product of the EXCELLENT Trial are excluded.
• Any other coexisting conditions that will preclude participation in the study or compromise ability to give informed consent

Where it is running

• CHU Montpellier Arnaud-De-Villeneuve — Montpellier, France (enrolling)
• Hôpital de Rangueil — Toulouse, France (enrolling)
• Institut Jacques Cartier — Massy, France
• Hôpital Haut Levèque — Pessac, France
• Ninewells Hospital & Medical School — Dundee, United Kingdom
• BIRMINGHAM, Queen Elizabeth Hospital ,Mindelsohn Way, — Edgbaston, United Kingdom
• University of Edinburgh — Edinburgh, United Kingdom
• GHRMSA — Mulhouse, France, France
• Saint Bartholomew's Hospital W Smithfield, — London, United Kingdom
• CHU DIJON Hôpital François Mitterrand 14 rue Gaffarel — Dijon, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.